1. What is BPC-157?

BPC-157 (Body Protective Compound-157) is a synthetic peptide fragment consisting of 15 amino acids, derived from a protein found in human gastric juice. It has been investigated in preclinical and experimental studies for its potential role in tissue repair, angiogenesis, and inflammation regulation. Research interest spans musculoskeletal models, gastrointestinal systems, vascular biology, and neurological pathways.

2. BPC-157 Structure

Sequence: Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-G|y-Leu-Val Molecular

Formula:C₆₂H₉₈N₁₆O₂₂

Molecular Weight: 1419.556g/mol

PubChem CID: 108101

3. BPC-157 Research

 Research Overview
BPC-157 has been studied in animal models and cell culture systems for its effects on angiogenesis, nitric oxide pathways, and cellular repair mechanisms 【1】.

【1】 Angiogenesis & Tissue Models
Studies suggest that BPC-157 may promote angiogenesis through VEGF signaling, fibroblast migration, and extracellular matrix remodeling, contributing to interest in tendon, ligament, and vascular research.

【2】 Vascular Pathways & Nitric Oxide System
BPC-157 has been observed to interact with nitric oxide signaling, influencing vascular tone, microvascular stability, and tissue oxygenation.

【3】 Neurological Models
In preclinical studies, BPC-157 has been reported to support neuronal survival, axon regeneration, and reduction of neuroinflammatory markers. Research interest includes neuropathy and spinal cord injury models.

【4】 Gastrointestinal Research
Because BPC-157 is derived from gastric proteins, much research has focused on its effects on the GI tract. In animal models, it has been associated with mucosal healing and reduced GI inflammation 【2】.

【5】 Systemic & Metabolic Research
Additional studies suggest roles in oxidative stress reduction, mitochondrial activity, and metabolic regulation, though these findings are preliminary and remain under investigation.

4. Future BPC-157 Research

Future research directions emphasize transitioning from animal and in-vitro models toward more robust evaluations in controlled human studies. Areas of interest include:

l Vascular biology and nitric oxide modulation 【3】

l Neurological research (neuroinflammation, axonal regeneration) 【4】

l Gastrointestinal models (mucosal healing and barrier function) 【5】

Researchers are also exploring pharmacokinetics, oral formulations, and potential analogs. At present, findings are experimental only, with no approved therapeutic applications.

5.Clinical Relevance

l BPC-157 is not approved for human therapeutic use. However, preclinical data has shown activity in models involving:

l Musculoskeletal injuries (tendons, ligaments, muscles)

l Gastrointestinal inflammation and ulcers

l Nerve injury and regeneration models

l Chronic wound and ischemia models 【6】

These results highlight why BPC-157 remains of strong scientific interest, but further controlled trials are required.

⚠ Disclaimer

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.